Trials / Completed
CompletedNCT01653145
Positive Energy I Through Overfeeding
Behavioral Response to Short-term (Two-day) Positive Energy Balance Through Overfeeding (ENERGY I)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Pennington Biomedical Research Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this trial is to examine the metabolic and behavioral effects of a positive energy balance induced by adding food to the usual level of activity. It is hypothesized that: 1) food intake will not differ significantly after 2 days of positive energy balance induced by a high carbohydrate vs. high fat diet when both diets are low in energy density, and 2) food intake will be higher after a positive energy balance induced by a high fat/high energy dense diet vs. a high fat/low energy dense diet.
Detailed description
The purpose of this trial is to examine the metabolic and behavioral effects of a positive energy balance induced by adding food to the usual level of activity. During this study, we will induce a positive energy balance for two days by increasing food intake to 140% of baseline energy requirements and keeping energy expenditure constant. The following three diets, which vary in dietary fat and energy density (kcal/g), will be used to induce the positive energy balance in a within subjects or cross over design: 1) high fat/high energy density, 2) high fat/low energy density, and 3) high carbohydrate/low energy density. Food intake and activity will be measured for 4 days after each diet to quantify the response to positive energy balance and manipulation of dietary fat and energy density.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Diet A | Dietary |
| OTHER | Diet B | Dietary |
| OTHER | Diet C | Dietary |
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2012-07-30
- Last updated
- 2016-01-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01653145. Inclusion in this directory is not an endorsement.